Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CDP-Choline and Working Memory After TBI
NCT00727246Phase 2Completed
- Start
- Mar 2009
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of citicoline in traumatic brain injury (TBI). Primary endpoints: Cognitive Composite Score for Group of Subjects With TBI and Healthy Controls Matched by Age, Education, and Treatment Group at 6 weeks and Cognitive Composite Score for Group of Subjects With TBI and Unmatched Healthy Controls at 6 weeks. Started Mar 2009; status: completed.
02
Drugs
citicoline
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT00727246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00727246.